butylated hydroxytoluene has been researched along with galantamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boğa, M; Ertaş, A; Oztürk, M; Topçu, G | 1 |
Dikmen, M; Karaküçük-İyidoğan, A; Karaman, N; Koçyiğit-Kaymakçıoğlu, B; Oruç-Emre, EE; Öztürk, M; Sıcak, Y; Taşkın-Tok, T | 1 |
Barbosa, FAR; Braga, AL; Canto, RFS; Rafique, J; Saba, S | 1 |
3 other study(ies) available for butylated hydroxytoluene and galantamine
Article | Year |
---|---|
Antioxidant and anticholinesterase activity evaluation of ent-kaurane diterpenoids from Sideritis arguta.
Topics: Antioxidants; Cholinesterase Inhibitors; Diterpenes, Kaurane; Molecular Structure; Plants, Medicinal; Sideritis; Stereoisomerism; Turkey | 2009 |
New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Antineoplastic Agents; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Drug Design; Humans; Hydrazones; Molecular Docking Simulation; Piperidines | 2016 |
Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Esters; Humans; Molecular Structure; Organoselenium Compounds; Pyrimidinones; Structure-Activity Relationship | 2016 |